Why It Matters This is the first human study to show that GLP-1 medications may help the body burn visceral fat more actively not just reduce calories in.That means the weight loss benefits could be coming from both appetite control and a metabolic boost
Although companies cannot control in the short-term the number of employees and dependents who fill GLP-1 prescriptions, they can adjust the value of the HRA at renewal based on total spend
Participants receiving 2.4mg weekly semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group
All eight forms of tocochromanols (-, -, -, and -tocopherols and -, -, -, and -tocotrienols) occur naturally in mostly plant-based foods but in varying amounts
Shannon CE, Nixon AV, et al